GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

FOIA requests to the federal government often are signals. They can be an important early warning of bad publicity, litigation to come, or uncertainties to be hedged and gamed out. When the flow of ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

(Journal of Clinical Endocrinology & Metabolism) At the start of the new year, Merck plans to cut the list price of its diabetes drugs sitagliptin (Januvia) and sitagliptin/metformin (Janumet ...

It is expected that the FDA will soon approve this generic as an obesity treatment since the obesity drug Saxenda has the same active ingredient and was released afterward. The generic of Victoza ...

A recent survey reveals a significant decline in teen drug and alcohol use since 2017, reaching its lowest point in 2024. Researchers attribute this drop to pandemic lockdowns disrupting social ...

The US drug regulator inspected Biocon's unit between ... for the generic versions of Victoza to treat Type-two Diabetes and Saxenda to treat weight management. Victoza and Saxenda are registered ...